Forest Sees Two Potential Fibromyalgia Indications For Milnacipran
Forest has two potential indications for its fibromyalgia therapy milnacipran, President & Chief Operating Officers Ken Goodman said during the firm's July 19 investor call
Forest has two potential indications for its fibromyalgia therapy milnacipran, President & Chief Operating Officers Ken Goodman said during the firm's July 19 investor call